ENTA — Enanta Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $339.02m
- $275.90m
- $65.32m
Enanta Pharmaceuticals Inc expected to post a loss of $1.16 a share - Earnings Preview
Brief: Enanta Pharmaceuticals Announces Positive Topline Results For EDP-323
Enanta Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Enanta Pharmaceuticals Q3 Revenue USD 17.971 Million Vs. IBES Estimate USD 17.2 Million
Enanta Pharmaceuticals Inc expected to post a loss of $1.45 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- ServiceNow, Ulta Beauty, Vertex Pharmaceuticals
Enanta Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Enanta Pharmaceuticals Q2 Revenue USD 17.054 Million Vs. IBES Estimate USD 16.5 Million
Enanta Pharmaceuticals Inc expected to post a loss of $1.33 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Costco Wholesale, S&P Global, Transdigm Group
Brief: Enanta Pharmaceuticals Q1 Revenue USD 18.003 Million
Enanta Pharmaceuticals Inc expected to post a loss of $1.19 a share - Earnings Preview
Enanta Pharmaceuticals Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Enanta Pharmaceuticals Sees Topline Data From At Least One Phase 2 Study of Zelicapavir in Q3 2024
Brief: Enanta Pharmaceuticals Files For Mixed Shelf Offering Of Up To $150 Million
U.S. RESEARCH ROUNDUP-Boot Barn Holdings, Hershey Co, Ulta Beauty
Brief: Enanta Pharmaceuticals Q4 Revenue USD 18.932 Million
U.S. RESEARCH ROUNDUP-Beacon Roofing Supply, Bioxcel Therapeutics, Cambium Networks
U.S. RESEARCH ROUNDUP-Alteryx, Axsome Therapeutics, Inogen